Aviti Print
NGS Sequencing with the AVITI™ System – Unlocking New Possibilities    

Print

The AVITI™ sequencing platform, launched by Element Biosciences in 2022, represents a significant advancement in next-generation sequencing (NGS) technology. Utilising an innovative approach called Avidity Sequencing™, AVITI improves upon many limitations of traditional sequencing-by-synthesis (SBS) methods, offering enhanced accuracy, reduced biases, and more efficient workflows.


Key Advantages of AVITI™ and Avidity Sequencing™

AVITI™ employs Sequencing by Binding (SBB) and utilises Rolling Circle Amplification (RCA) instead of PCR-based amplification (used in Illumina platforms). This PCR-free amplification method delivers high-quality reads with improved accuracy and reduced artefacts:

Core Features Driving Superior Performance

1.PCR-free, isothermal RCA from circular DNA libraries:

2. Use of avidites - molecules that bind to DNA with high specificity:

3. Dense polony formation - hundreds of molecular copies form in close proximity, enabling efficient reagent use and strong signal detection.

4. Negligible index hopping (close to 0%) - a critical advantage for highly multiplexed or contamination-sensitive applications (e.g., single-cell RNA-Seq, metabarcoding). Achieved through:


Seamless Integration with Existing NGS Workflows

AVITI is fully compatible with established protocols:


Genomed S.A. AVITI Sequencing Services

Genomed S.A. offers comprehensive NGS services using the AVITI™ System, including:

We also provide:

Please contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it for assistance in designing experiments or if you have any questions about NGS and pricing.